Header Logo

Connection

RACHELLE DOODY to Levodopa

Back to Details
This is a "connection" page, showing publications RACHELLE DOODY has written about Levodopa.
RACHELLE DOODY
Connection Strength
0.058
Levodopa
  1. A Phase 2b, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of intravenous prasinezumab in early-stage Parkinson's disease (PADOVA): Rationale, design, and baseline data. Parkinsonism Relat Disord. 2025 Mar; 132:107257.
    View in: PubMed
    Score: 0.058
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.